15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 11 firms covering Corpay Inc, 8 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $340.00 to $415.00, so the covering firms are broadly aligned. The average target of $384.09 is roughly in line with the current $384.28. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $7.04 next quarter toward $30.60 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 ratings
Moderate Buy
Strong Buy00%
Buy873%
Hold327%
Sell00%
Strong Sell00%
Based on 11 analysts giving stock ratings to Corpay Inc.
As of Jul, 8 of 11 firms rate CPAY a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CPAY EPS & revenue forecast
EPS · NEXT QUARTER
$7.04
Range $6.80 – $7.44 · 15 analysts · +23% YoY
Next period, 15 analysts expect Corpay Inc to earn $7.04 a share (range $6.80 – $7.44), versus $5.70 a year earlier. Full-year consensus is $26.77, growing to $30.60 the year after.
REVENUE · NEXT QUARTER
$1.3B
Range $1.3B – $1.4B · 15 analysts · +15% YoY
Revenue is expected to reach $1.3B (range $1.3B – $1.4B), +15.0% year-over-year. Full-year consensus is $5.3B, rising to $5.8B next year.
Top analysts covering Corpay Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CPAY.
#1
Daniel Perlin
RBC Capital · Rank #381
Hold
$363.00-5.5% to target
Overall win rate
20%
+ Follow
#2
Sanjay Sakhrani
Keefe, Bruyette & Woods
Buy
$400.00+4.1% to target
Coverage
—
+ Follow
#3
Rayna Kumar
Oppenheimer
Buy
$388.00+1.0% to target
Coverage
—
+ Follow
#4
Roger Boyd
UBS
Hold
$380.00-1.1% to target
Coverage
—
+ Follow
#5
James Faucette
Morgan Stanley
Buy
$390.00+1.5% to target
Coverage
—
+ Follow
CPAY stock forecast FAQ
What is CPAY's average 12-month price target?+
The 11 analysts with a live target average $384.09 for Corpay Inc over the next 12 months, ranging from a $415.00 high to a $340.00 low.
Is CPAY stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 11 analyst ratings, 8 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CPAY?+
The Street-high target is $415.00 (Cantor Fitzgerald), and the Street-low is $340.00 (Mizuho). The average of all 11 active targets is $384.09.
How many Wall Street analysts cover CPAY?+
11 analysts have an active rating on Corpay Inc, and 11 firms carry a live 12-month price target.
Who is the most accurate analyst covering CPAY?+
Among analysts who currently cover CPAY, Daniel Perlin of RBC Capital has the strongest overall Quantellect track record (Rank #381). Their current call is Hold with a $363.00 target.
What is Corpay Inc's projected EPS for next quarter?+
The consensus estimate is $7.04 per share (range $6.80 – $7.44) across 15 analysts. Full-year EPS is projected at $26.77, rising to $30.60 the following year.
How much revenue is Corpay Inc expected to report next quarter?+
Consensus revenue is $1.3B (range $1.3B – $1.4B). Full-year revenue is projected at $5.3B, growing to $5.8B next year.
Have analysts been upgrading or downgrading CPAY lately?+
As of Jul, 8 of 11 firms rate CPAY a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CPAY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
